The Service Tree lists all services in "branched" groups, starting with the very general and moving to the very specific. Click on the name of any group name to see the sub-groups available within it. Click on a service code to see its details and the providers who offer that service.
Immunizations
Programs that provide inoculations which prevent adolescents and adults who have never had the illness and/or who were not vaccinated as children from contracting chickenpox (varicella), an acute viral disease with mild constitutional symptoms (headache, fever, malaise) followed by a series of outbreaks of macules, papules, blisters and crusting. Vaccination is recommended for persons of any age without a reliable history of varicella disease or vaccination, susceptible adolescents and adults living in a household with children, susceptible health care workers, individuals at high risk for exposure (e.g., teachers, day care employees, staff in institutional settings), nonpregnant women of childbearing age and international travelers.
Programs that inoculate infants and young children to prevent them from contracting diseases to which they are particularly susceptible including diphtheria, tetanus (lockjaw), measles, mumps, chicken pox (varicella), rubella (German measles), whooping cough (pertussis), Hib (haemophilus influenzae type B), hepatitis B, pneumococcal infections and polio. Hepatitis A vaccine is recommended for use in selected locales and for certain high-risk groups. Influenza vaccine is recommended annually for children older than six months with specific risk factors. Rotavirus vaccination (to prevent acute gastroenteritis with vomiting and severe diarrhea) is recommended during the first year of infancy. A baby should receive two or three doses depending on the brand used. Some childhood immunizations involve a series of doses at specific intervals.
Programs that inoculate susceptible individuals of all ages, but particularly people who are very young or very old, to prevent them from contracting any of the variant strains of influenza that are prevalent during the winter and spring. The vaccine may be administered as a "shot" that is given with a needle, usually in the arm, or in the form of a nasal mist.
Programs that provide inoculations which prevent high risk populations from contracting hepatitis A, an inflammation of the liver caused by the hepatitis A virus (HAV) which can be contracted through contaminated water or food. Included are persons traveling to or working in countries with high rates of infection, sexually active gay/bisexual men, injecting and non-injecting illegal drug users, persons who work with HAV-infected primates in a laboratory setting, persons with chronic liver disease, persons with clotting disorders and, where cost-effective, food handlers. The vaccine is administered in a two-dose regimen separated by a period of six months to a year.
Programs that provide inoculations that protect at risk populations including sexually active gay/bisexual men, injecting and non-injecting drug users, health care workers and heterosexuals who have multiple sex partners from contracting hepatitis B, an inflammation of the liver. Hepatitis B vaccine is also recommended for all adolescents who may not have received it during infancy or childhood. The vaccine is administered in a three-dose regimen over a period of six months.
Programs that provide inoculations which provide some measure of protection against the human papillomavirus, a sexually transmitted disease some strains of which have been shown to be a major cause of cervical cancer. HPV has also been linked to cancer of the anus, vulva, vagina and some cancers of the oropharynx (the middle part of the throat that includes the soft palate, the base of the tongue and the tonsils). Some studies indicate that it may also be a risk factor for cancer of the penis.
Measles/Mumps/Rubella Immunizations
Programs that provide inoculations which prevent adults from contracting measles, mumps or rubella (German measles). These vaccines are often given in a combined form (MMR), which is appropriate even though an individual is already immune to one or more of the components. Vaccination is recommended for adults born after 1956 without written documentation of immunization on or after their first birthday; health care personnel born after 1956 who are at risk of exposure to patients with one of the diseases; HIV-infected individuals without severe immunosuppression; travelers to foreign countries; and persons entering post-secondary educational institutions (e.g., college).
Pneumococcal Pneumonia Immunizations
Programs that provide inoculations which protect susceptible people from contracting pneumococcal pneumonia. Vaccination is recommended for adults age 65 and older; persons with cardiovascular or pulmonary disorders including congestive heart failure, diabetes mellitus, chronic liver disease, alcoholism, CSF leaks, cardiomyopathy, COPD or emphysema; persons with splenic dysfunction or asplenia, hematologic malignancy, multiple myeloma, renal failure, organ transplantation or immunosuppressive conditions including HIV infections; and Alaskan Natives and certain Native American populations.
Pre/Post-Exposure Rabies Immunizations
Programs that provide inoculations which prevent contraction of rabies, a viral infection which affects the central nervous system, for individuals whose occupations put them at high risk for exposure (e.g., animal handlers, laboratory workers, forest rangers, taxidermists, veterinarians, animal breeders and hunters) and for individuals who have been exposed to rabies immediately after the exposure occurs. Other individuals whose activities bring them into frequent contact with the rabies virus or potentially rabid bats, raccoons, skunks, cats, dogs or other species at risk of having rabies; and international travelers likely to come in contact with animals in areas of enzootic dog rabies which lack immediate access to appropriate medical care, including biologics, should also be considered for pre-exposure prophylaxis. There is no treatment for rabies once symptoms of the disease appear.
Programs that provide the Shingrix (recombinant zoster vaccine, or RZV) inoculations which prevent recipients from contracting shingles (herpes zoster). The vaccine is recommended for adults age 50 and older without contraindications, and adults 19 years and older who are immunocompromised. It is administered in a two dose schedule separated by two to six months. The vaccine cannot be used to treat the disease or post-herpetic neuralgia (pain after the rash is gone) once it develops, but can prevent future occurrences. The previously approved and used Zostavax vaccine is no longer available for use in the United States.
Programs that provide inoculations for adolescents and adults which protect them from contracting tetanus, diphtheria and/or pertussis (whooping cough) depending on which vaccines (Td or Tdap) are administered. Td is a tetanus-diphtheria vaccine given to adolescents and adults as a booster shot every 10 years, or after an exposure to tetanus under some circumstances. Tdap is similar to Td but also contains protection against pertussis; and can be given regardless of when Td was last received. Adolescents age 11-18 (preferably at the age of 11-12) and adults age 19 through 64 should receive a single dose of Tdap. Adults age 65 and older who have close contact with an infant and have not previously received Tdap, should also receive a single dose. Tdap should also be given to 7-10 year olds who are not fully immunized against pertussis. Inoculations are recommended for people in flooded areas who may be at risk of tetanus infections from dirty cuts, scrapes or puncture wounds.
Programs that provide inoculations to prevent individuals who will be traveling outside the U.S., Canada and Europe from contracting infectious diseases such as typhoid, typhus, hepatitis A and B, malaria, dysentery or yellow fever.